<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cntx-20260427.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001842952</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c-1" id="f-2">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-3">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-4">0001842952</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Context Therapeutics Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-5">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c-1" id="f-6">&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established processes designed to ensure that the timing of any option grants and other awards to executive officers is not influenced by material nonpublic information (&#x201c;MNPI&#x201d;), and grants are generally made on a predetermined schedule, usually in February of each year, regardless of any upcoming announcements or events that could impact our share price. The Compensation Committee carefully reviews any potential MNPI before granting options and may delay a grant if necessary to avoid any appearance of impropriety related to the timing of the award.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c-1" id="f-7">We have established processes designed to ensure that the timing of any option grants and other awards to executive officers is not influenced by material nonpublic information (&#x201c;MNPI&#x201d;), and grants are generally made on a predetermined schedule, usually in February of each year, regardless of any upcoming announcements or events that could impact our share price.</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c-1" id="f-8">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgMethodTextBlock contextRef="c-1" id="f-11">The Compensation Committee carefully reviews any potential MNPI before granting options and may delay a grant if necessary to avoid any appearance of impropriety related to the timing of the award.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c-1" id="f-9">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c-1" id="f-10">false</ecd:MnpiDiscTimedForCompValFlag>
</xbrl>
